NCT07159581View on ClinicalTrials.gov

Gene Therapy for Wilson Disease Evaluated by 64Cu PET/CT

Enrolling by invitationOBSERVATIONAL

Enrollment

5

Participants

Timeline

Start Date

July 8, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Wilson Disease

Trial Locations (1)

8200

Aarhus University Hospital, Aarhus

All Listed Sponsors

collaborator

Ultragenyx Pharmaceutical Inc

INDUSTRY

lead

Thomas Damgaard Sandahl

OTHER